Renaissance Technologies (RenTech)'s MPLT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 6,937 shares of MapLight Therapeutics, Inc. (MPLT) worth $248,622, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Renaissance Technologies (RenTech) has initiated a new position in MPLT, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s MapLight Therapeutics (MPLT) Holding Value Over Time
Track share changes against reported price movement
Quarterly MapLight Therapeutics (MPLT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +6,937 | New Buy | 6,937 | $35.84 |
Renaissance Technologies (RenTech)'s MapLight Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased MapLight Therapeutics, Inc. (MPLT) in Q2 2026, acquiring 6,937 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held MapLight Therapeutics, Inc. (MPLT) for 1 quarters since Q2 2026.
Renaissance Technologies (RenTech)'s largest addition to MapLight Therapeutics, Inc. (MPLT) was in Q2 2026, adding 6,937 shares worth $248,622.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 6,937 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $248,622.
As of the Q2 2026 filing, MapLight Therapeutics, Inc. (MPLT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in MapLight Therapeutics, Inc. (MPLT) was 6,937 shares, as reported at the end of Q2 2026.